Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma
NCT07551349
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Interventions
BIOLOGICAL:
EB-701/CA9-NK
DRUG:
Fludarabine
Sponsor
Beijing Biotech